The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
ID 22280 | Last update: 17.07.2024
REACH Authorisation Decisions List of authorisation decisions adopted on the basis of Article 64 of Regul...
Regolamento (UE) 2020/878 della Commissione del 18 giugno 2020 che modifica l’allegato II del regolamento (CE) n. 1907/2006 del Parlamento...
La Commissione europea ha preparato un documento sulle misure che le autorità nazionali potrebbero utilizzare (o hanno già utilizzato) p...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
